The data to be presented encompasses five of the company’s novel drug candidates: BCR-ABL tyrosine kinase inhibitor olverembatinib (HQP1351), Bcl-2 inhibitor lisaftoclax (APG-2575), FAK/ALK/ROS1 ...

Classic car collectors will have a rare opportunity to bid on three exceptional vintage automobiles at the 6th Annual ...

PARP7 is a mono-ADP-ribosyl transferase (mono-ART) which has recently gained attention due to its emerging role as a negative ...

Wojciech Jurczak, MD, PhD, discusses advancements in B-cell lymphoma therapy, focusing on immunotherapy, molecular-targeted agents, and more.

The mutation burden in DLBCL varies significantly based on patient sex and age, according to recent findings published in ...

Preclinical models of Parkinson's disease (PD) have been developed using intracerebroventricular (i.c.v.) injection of 6-hydroxydopamine (6-OHDA) to induce neurodegeneration and motor dysfunction.

During a Case-Based Roundtable® event, Ryan W. Jacobs, MD, discussed a patient who received 2 prior lines of therapy for ...

A recent study published on January 31, 2024, in Nature Aging introduces a potential new drug that could help. Scientists believe this drug can remove harmful “zombie” cells from the liver and slow ...

The inclusion criteria for patients were as follows: (1) no previous chemotherapy or targeted therapy; (2) pathologically confirmed DLBCL exhibiting co-expression of MYC (≥40%) and BCL2 (>50%) (2, 4); ...

Investigators found that lipid metabolism disruptions spark T-cell dysfunction in patients with chronic lymphocytic leukemia.

Students at Shahjalal University of Science and Technology (SUST) barred a Chhatra League activist from attending classes today (11 March) and later handed him over to the police. Nur Md Bayezid, a ...